Stocks · Health care · Surgical & Medical Instruments & Apparatus

INTEGRA LIFESCIENCES HOLDINGS CORP

IART Clue Score37
United States Fiscal year ends December CIK 0000917520
$13.44 +0.22% Close, 9 Oct 2026
Price $13.44 −79.81% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue992.1Operating income115.3Net income74.6EPS, diluted0.94Fiscal year 2017Revenue1,188.2 +19.8%Operating income44.8Net income64.7 −13.2%EPS, diluted0.82 −12.8%Fiscal year 2018Revenue1,472.4 +23.9%Operating income111.0Net income60.8 −6.1%EPS, diluted0.72 −12.2%Fiscal year 2019Revenue1,517.6 +3.1%Operating income93.8Net income50.2 −17.4%EPS, diluted0.58 −19.4%Fiscal year 2020Revenue1,371.9 −9.6%Operating income151.4Net income133.9 +166.7%EPS, diluted1.57 +170.7%Fiscal year 2021Revenue1,542.4 +12.4%Operating income197.2Net income169.1 +26.3%EPS, diluted1.98 +26.1%Fiscal year 2022Revenue1,557.7 +1.0%Operating income238.9Net income180.6 +6.8%EPS, diluted2.16 +9.1%Fiscal year 2023Revenue1,541.6 −1.0%Operating income111.5Net income67.7 −62.5%EPS, diluted0.84 −61.1%Fiscal year 2024Revenue1,610.5 +4.5%Operating income28.4Net income−6.9 −110.3%EPS, diluted−0.09 −110.7%Fiscal year 2025Revenue1,635.2 +1.5%Operating income−493.4Net income−516.5EPS, diluted−6.74
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 992.1 1,188.2 1,472.4 1,517.6 1,371.9 1,542.4 1,557.7 1,541.6 1,610.5 1,635.2
Growth +19.8% +23.9% +3.1% −9.6% +12.4% +1.0% −1.0% +4.5% +1.5%
Operating income 115.3 44.8 111.0 93.8 151.4 197.2 238.9 111.5 28.4 −493.4
Net income 74.6 64.7 60.8 50.2 133.9 169.1 180.6 67.7 −6.9 −516.5
Growth −13.2% −6.1% −17.4% +166.7% +26.3% +6.8% −62.5% −110.3%
EPS, diluted 0.94 0.82 0.72 0.58 1.57 1.98 2.16 0.84 −0.09 −6.74
Growth −12.8% −12.2% −19.4% +170.7% +26.1% +9.1% −61.1% −110.7%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin64.8%Operating margin11.6%Net margin7.5%Free cash flow margin7.0%Fiscal year 2017Gross margin63.3%Operating margin3.8%Net margin5.4%Free cash flow margin6.0%Fiscal year 2018Gross margin61.2%Operating margin7.5%Net margin4.1%Free cash flow margin8.3%Fiscal year 2019Gross margin62.8%Operating margin6.2%Net margin3.3%Free cash flow margin10.7%Fiscal year 2020Gross margin62.0%Operating margin11.0%Net margin9.8%Free cash flow margin12.0%Fiscal year 2021Operating margin12.8%Net margin11.0%Free cash flow margin17.1%Fiscal year 2022Operating margin15.3%Net margin11.6%Free cash flow margin14.3%Fiscal year 2023Operating margin7.2%Net margin4.4%Free cash flow margin4.7%Fiscal year 2024Operating margin1.8%Net margin−0.4%Free cash flow margin1.6%Fiscal year 2025Operating margin−30.2%Net margin−31.6%Free cash flow margin−1.9%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 64.8% 63.3% 61.2% 62.8% 62.0% n/a n/a n/a n/a n/a
Operating margin 11.6% 3.8% 7.5% 6.2% 11.0% 12.8% 15.3% 7.2% 1.8% −30.2%
Net margin 7.5% 5.4% 4.1% 3.3% 9.8% 11.0% 11.6% 4.4% −0.4% −31.6%
Free cash flow margin 7.0% 6.0% 8.3% 10.7% 12.0% 17.1% 14.3% 4.7% 1.6% −1.9%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow116.4Capital expenditure−47.3Free cash flow69.1Fiscal year 2017Operating cash flow114.5Capital expenditure−43.5Free cash flow71.0 +2.8%Fiscal year 2018Operating cash flow199.7Capital expenditure−77.7Free cash flow121.9 +71.7%Buybacks0.0Fiscal year 2019Operating cash flow231.4Capital expenditure−69.5Free cash flow161.9 +32.8%Buybacks0.0Fiscal year 2020Operating cash flow203.8Capital expenditure−38.9Free cash flow164.9 +1.9%Buybacks−100.0Fiscal year 2021Operating cash flow312.4Capital expenditure−48.0Free cash flow264.4 +60.3%Buybacks0.0Fiscal year 2022Operating cash flow264.5Capital expenditure−42.3Free cash flow222.1 −16.0%Buybacks−125.0Fiscal year 2023Operating cash flow140.0Capital expenditure−66.9Free cash flow73.1 −67.1%Buybacks−275.0Fiscal year 2024Operating cash flow129.4Capital expenditure−104.4Free cash flow25.0 −65.8%Buybacks−52.5Fiscal year 2025Operating cash flow50.4Capital expenditure−81.4Free cash flow−31.1 −224.4%Buybacks−0.2
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 116.4 114.5 199.7 231.4 203.8 312.4 264.5 140.0 129.4 50.4
Capital expenditure −47.3 −43.5 −77.7 −69.5 −38.9 −48.0 −42.3 −66.9 −104.4 −81.4
Free cash flow 69.1 71.0 121.9 161.9 164.9 264.4 222.1 73.1 25.0 −31.1
Growth +2.8% +71.7% +32.8% +1.9% +60.3% −16.0% −67.1% −65.8% −224.4%
Buybacks n/a n/a 0.0 0.0 −100.0 0.0 −125.0 −275.0 −52.5 −0.2

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash102.1Shareholders’ equity839.7Fiscal year 2017Cash174.9Shareholders’ equity962.3Fiscal year 2018Cash138.8Total debt900.0Net cash (debt)−761.2Shareholders’ equity1,375.8Debt to equity0.65Fiscal year 2019Cash198.9Total debt877.5Net cash (debt)−678.6Shareholders’ equity1,416.7Debt to equity0.62Fiscal year 2020Cash470.2Total debt877.5Net cash (debt)−407.3Shareholders’ equity1,514.9Debt to equity0.58Fiscal year 2021Cash513.4Total debt843.8Net cash (debt)−330.3Shareholders’ equity1,684.8Debt to equity0.50Fiscal year 2022Cash456.7Total debt775.0Net cash (debt)−318.3Shareholders’ equity1,804.4Debt to equity0.43Fiscal year 2023Cash276.4Total debt775.0Net cash (debt)−498.6Shareholders’ equity1,587.9Debt to equity0.49Fiscal year 2024Cash246.4Total debt760.5Net cash (debt)−514.1Shareholders’ equity1,545.3Debt to equity0.49Fiscal year 2025Cash235.0Total debt726.6Net cash (debt)−491.5Shareholders’ equity1,043.5Debt to equity0.70
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 102.1 174.9 138.8 198.9 470.2 513.4 456.7 276.4 246.4 235.0
Total debt n/a n/a 900.0 877.5 877.5 843.8 775.0 775.0 760.5 726.6
Net cash (debt) n/a n/a −761.2 −678.6 −407.3 −330.3 −318.3 −498.6 −514.1 −491.5
Shareholders’ equity 839.7 962.3 1,375.8 1,416.7 1,514.9 1,684.8 1,804.4 1,587.9 1,545.3 1,043.5
Debt to equity n/a n/a 0.65 0.62 0.58 0.50 0.43 0.49 0.49 0.70

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
64.8% 63.3% 61.2% 62.8% 62.0% n/a n/a n/a n/a n/a
11.6% 3.8% 7.5% 6.2% 11.0% 12.8% 15.3% 7.2% 1.8% −30.2%
9.1% 1.0% 3.9% 4.0% 6.8% 13.9% 13.7% 5.3% −1.1% −34.5%
7.5% 5.4% 4.1% 3.3% 9.8% 11.0% 11.6% 4.4% −0.4% −31.6%
7.0% 6.0% 8.3% 10.7% 12.0% 17.1% 14.3% 4.7% 1.6% −1.9%
Spending
5.9% 5.3% 5.3% n/a n/a n/a n/a n/a n/a n/a
45.9% 52.5% 46.9% 45.3% 43.3% 41.3% 39.6% 42.6% 44.5% 42.8%
4.8% 3.7% 5.3% 4.6% 2.8% 3.1% 2.7% 4.3% 6.5% 5.0%
17.5% −468.7% −5.9% 16.5% −43.2% 21.2% 15.6% 16.4% n/a n/a
Returns
8.9% 6.7% 4.4% 3.5% 8.8% 10.0% 10.0% 4.3% −0.4% −49.5%
4.1% 2.0% 2.0% 1.5% 3.7% 4.5% 4.6% 1.8% −0.2% −14.3%
Balance and payout
n/a n/a 0.65 0.62 0.58 0.50 0.43 0.49 0.49 0.70
53.6% 70.0% 55.7% 57.1% 58.1% 55.5% 53.6% 58.0% 61.7% 71.0%
n/a n/a 0.0% 0.0% 60.6% 0.0% 56.3% 376.2% 210.2% n/a